Akèy › Kansè (tout kalite) › Oregon › Eugene
Etid klinik pou Kansè (tout kalite) nan Eugene, OR
6 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Eugene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Ap rekriteFaz 3
- Williamette Valley Cancer Institute and Research Center, Eugene
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Ap rekriteFaz 3
- Willamette Valley Cancer Institute and Research Center /ID# 280617, Eugene
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- Willamette Valley Cancer Institute, Eugene
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- USO - Oncology Associates of Oregon, Eugene
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ap rekriteFaz 2
- 517, Eugene
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1
- Willamette Valley Cancer Institute and Research Center /ID# 267088, Eugene
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY110 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Durham, NC58 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Seattle, WA49 etid
- Atlanta, GA49 etid
- Arlington, VA48 etid
Lòt etid nan Eugene
- Kansè Poumon ki pa ti selil13 etid
- Kansè ovè9 etid
- Kansè Endomèt8 etid
- Kansè nan tete7 etid
- Lukemi lenfositè kwonik6 etid
- Myelom Miltip6 etid
- Kansè Metastatik6 etid
- Itilizasyon Dwòg ak Depandans5 etid
- Kansè poumon5 etid
- Degeneresans makile5 etid
- Obèsite4 etid
- Kansè pwostat3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.